Chadi Nabhan, Hematologist and Medical Oncologist, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X:
“TILs in melanoma.
Daniel Olson of UChicagoCancerCenter joined Healthcare Unfiltered to discuss this important topic and therapy:
- What is the data?
- How to overcome logistical challenges?
- Where do TILs fit in treating melanoma?
Dan is amazing; check it out.”
Other articles featuring Dr. Nabhan on OncoDaily.